Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flash BioSolutions
Toulouse, Occitanie, France
- Ownership
- Private
- Employees
- ~11
- Development stage
- Other
01
Overview
Flash BioSolutions served as a gene therapy CDMO specializing in production of lentiviral and RNA vectors, supporting numerous client programs across research, clinical, and commercial phases. Granted Pharmaceutical Establishment status in 2024; ceased operations in early 2025[3][4].
- Therapeutic areas
- ImmunologyInfectious DiseasesRare DiseasesOther
- Modalities
- Lentiviral vectorRNA vectorViral vectorDNA deliverymRNA vaccineGene therapyVaccineSmall moleculeSynthetic oligonucleotide
- Industry
- Contract Manufacturing Organization
02
Partnerships
Collaborations with biopharma and biotechnology companies for vector manufacturing (unlisted; not specified by name)[1][5]
Beyond the preview
Go deeper on Flash BioSolutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Flash BioSolutions.